Publications
- Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic – BIBY-II study (observations lasting 24 months)2013 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Diabetes mellitus and insulin resistance, dyslipidemia, hypertension, gout2013 | Second Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic – BIBY-I study (observations lasting 3 to 12 months)2013 | Second Faculty of Medicine
- Must the start of insulin treatment in type 2 diabetes patients be connected with increasing of their body weight?2013 | Second Faculty of Medicine
- Effect of the incretin mimetic liraglutide (Victoza) on body weight and glycated hemoglobin levels in patients with type 2 diabetes mellitus in diabetology offices in Czech Republic: the BIVI study2013 | Second Faculty of Medicine
- Case reports of patients from the study BIBY or how does exenatide work in patients with type 2 diabetes mellitus2013 | Second Faculty of Medicine
- Diabetes mellitus and the brain2013 | Second Faculty of Medicine
- Rosiglitazon v léčbě diabetes mellitus 2. typu - zkušenosti diabetologů v České republice - 1. část: kompenzace diabetu, glukózový metabolismus2004 | First Faculty of Medicine
- Diabetes mellitus and metabolic syndrome2004 | First Faculty of Medicine
- Effect of rosiglitazone on microvascular reactivity in type 2 diabetic patientsPublication without faculty affiliation
Loading network view...